Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties

Jialei Yang1, Jinye Zhao2, Houchang Liu1

  • 1Department of Medical Laboratory Medicine, The People's Hospital of Dehong Prefecture, Mangshi, 678400, Yunnan, China.

Discover Oncology
|May 22, 2026
PubMed

Insights

Leucine-rich repeats containing G protein-coupled receptor 4 (LGR4) is vital in cancer progression and metastasis. This review explores LGR4

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Leucine-rich repeats containing G protein-coupled receptor 4 (LGR4) is a key receptor in G-protein-coupled receptor superfamily.
  • LGR4 is activated by ligands like R-spondins (RSPOs), Norrin, and RANKL, regulating critical signaling pathways.
  • It plays essential roles in organ development and maintenance, controlling cell proliferation, survival, and differentiation via the Wnt/β-catenin pathway.

Purpose of the Study:

  • To review the expression and functional roles of LGR4 in various tumors.
  • To elucidate the molecular mechanisms governed by LGR4 in cancer.
  • To examine the intricate relationship between LGR4, tumor stem cells, and chemotherapy resistance.

Main Methods:

  • Literature review of existing studies on LGR4 in cancer.
  • Analysis of LGR4's involvement in tumor progression, invasion, and metastasis.
  • Investigation of LGR4's role in regulating tumor stem cell populations and self-renewal.

Main Results:

  • LGR4 is implicated in the progression, invasion, and metastasis of multiple cancers (colorectal, breast, prostate, lung, skin).
  • LGR4 significantly influences tumor stem cell populations, modulating their self-renewal and stemness characteristics.
  • LGR4 is linked to chemotherapy resistance in various cancer types.

Conclusions:

  • LGR4 is a critical regulator in tumor development and progression.
  • Targeting LGR4 may offer novel therapeutic strategies for cancer, particularly concerning tumor stem cells and resistance.
  • Further research into LGR4's mechanisms is crucial for advancing cancer treatment.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...